I. Status in the world In July 2000, Da Vinci became the world’s first robotic surgical system that can be officially used in hospital operating rooms after being approved by the FDA. The robotic surgery system was mainly used for laparotomy in the early stage, but after continuous exploration and practice, the da Vinci system was successfully applied to direct heart surgery in 2003. Since the clinical application of fully robotic minimally invasive cardiac surgery is technically demanding and difficult to implement, only a few cardiac centers in the world can perform such surgery, and they are concentrated in the United States, Europe and other developed countries and regions. Currently, the number of robotic cardiac surgeries performed in the United States is about 1,700 cases per year, and is growing at a rate of 25% per year. In Asia, Japan, South Korea and international and regional regions such as Hong Kong and Taiwan in China have introduced the da Vinci robotic surgery system before 2007, but it is mainly used in laparotomy. Plagued by the difficulty of surgical technology, the number and types of cardiac surgeries carried out under full robots are extremely limited and in a stagnant state. II. Status in China As the first unit to introduce robotic surgery system in China, the cardiovascular surgery department of PLA General Hospital carried out the first domestic fully robotic minimally invasive cardiac surgery in January 2007. At present, 450 cases of various fully robotic cardiac surgeries have been completed, achieving the introduction of robotic surgery and technology transformation, which is a milestone in the field of minimally invasive surgery. Driven by cardiovascular surgery, da Vinci robotic surgery technology has been increasingly and widely used in many disciplines such as urology, general surgery, thoracic surgery, obstetrics and gynecology in PLA General Hospital. Driven and influenced by the PLA General Hospital, 12 units in China now have da Vinci robotic surgery systems and are starting to train and conduct surgeries in cardiac and other specialties. Up to now, except for PLA General Hospital, only Zhongshan Hospital of Fudan University in Shanghai has carried out minimally invasive robotic cardiac surgery with limited number and types of diseases. III. 4 years of robotic minimally invasive cardiac surgery in 301 Hospital In 2007, the PLA General Hospital was the first in China to introduce the da Vinci Surgical System, and Professor Gao Changqing formed the first robotic cardiac surgery team in China, and completed the first robotic unthoracic minimally invasive cardiac surgery in China on January 15, 2007, which pioneered the robotic minimally invasive cardiac surgery in China, and has since completed Since then, 450 cardiac surgeries have been performed, all of which have been successful, covering all the cardiac surgeries that can be performed by the da Vinci robotic system in the world, including coronary artery bypass grafting, mitral valvuloplasty and replacement, tricuspid valvuloplasty, atrial septal defect and ventricular septal defect repair, partial endocardial cushion defect repair, pulmonary vein ectopic drainage correction, heart and mediastinal tumor resection, etc. Among them, the non-thoracic and Coronary artery bypass grafting under non-extracorporeal heartbeat is the current minimally invasive limit of robotic cardiac surgery and the limit of what all robotic surgery can achieve, and only a few cardiac surgeons in the world are able to complete this surgery. The Cardiovascular Surgery Department of the PLA General Hospital is the cardiac surgery center with the largest variety of robotic cardiac surgeries completed by a single center in the world, including 24 procedures, six of which are world firsts. The postoperative pain is mild, the postoperative time in the care unit is shortened from 2 to 3 days to 1 day, and the patient can get out of bed on the first day, and the bleeding, hospital stay, and postoperative recovery are significantly better than those of conventional open heart surgery, which is unanimously affirmed by patients; especially the good cosmetic effect – no scar of conventional surgical incision is highly praised. Now, we have established a surgical technique scheme suitable for national conditions and innovatively expanded the scope of cardiovascular surgery applications. The number, quality and types of minimally invasive robotic cardiac surgery performed are among the leading in the world and among the highest in Asia, and have been reported by many media such as CCTV news broadcast, causing great repercussions in China. In 2008, the first Minimally Invasive Robotic Cardiac Surgery Center was established in China, and in 2010, the International Cooperation and Research Center for Robotic Cardiac Surgery was established. In 2008, “Minimally Invasive Robotic Cardiac Surgery” won the first prize of the excellent TV teaching material of the whole army. 2010 “In 2008 and 2010, the Cardiovascular Surgery Department of PLA General Hospital has successfully held two “International Robotic Cardiac Surgery Demonstration and Symposium”. “More than 300 international scholars and experts attended the conference and highly recognized and praised China’s achievements in robotic minimally invasive cardiac surgery. At present, the technology has been listed in the most authoritative “Huangjiayi Surgery” in China. more than 40 related papers have been published in the past 4 years, and 4 projects at all levels such as General Post and Beijing have been awarded, and more than 10 doctoral and master students have been trained. Prof. Changqing Gao has also been invited several times to attend international top academic conferences and give presentations on robotic minimally invasive cardiac surgery, which has greatly improved and consolidated China’s international leading position in this field of technology. Compared with traditional cardiac surgery, robotic minimally invasive cardiac surgery can minimize the trauma to patients and make the operation more delicate and accurate. It can also speed up patient recovery, reduce the chance of related complications, shorten hospitalization time, and to a certain extent, reduce the medical expenses of patients and lower medical costs. At the same time, it can significantly improve the quality of life, with small surgical scar, beautiful incision and light psychological burden for patients. The combination of robotic surgery and telemedicine allows physicians to remotely operate the robot via the Internet. The development of robotic cardiac surgery will not only bring a series of technical changes in terms of precise positioning, minimal surgical trauma, and surgical quality, but will also change many concepts of conventional surgery and will promote significant changes in the traditional medical model. With the further development of remote control technology, the da Vinci robotic surgery system will likely be increasingly used for remote surgery and to enable remote surgery in extreme environments such as war and earthquakes.